These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8380291)

  • 1. Immune responses to varicella zoster virus infections in healthy children.
    Rotbart HA; Levin MJ; Hayward AR
    J Infect Dis; 1993 Jan; 167(1):195-9. PubMed ID: 8380291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children.
    Englund JA; Arvin AM; Balfour HH
    J Clin Microbiol; 1990 Oct; 28(10):2327-30. PubMed ID: 2172288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella in children with perinatally acquired human immunodeficiency virus infection.
    Kelley R; Mancao M; Lee F; Sawyer M; Nahmias A; Nesheim S
    J Pediatr; 1994 Feb; 124(2):271-3. PubMed ID: 8301436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to varicella-zoster virus 5 years after acyclovir therapy of childhood varicella.
    Levin MJ; Rotbart HA; Hayward AR
    J Infect Dis; 1995 May; 171(5):1383-4. PubMed ID: 7751725
    [No Abstract]   [Full Text] [Related]  

  • 5. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group.
    Balfour HH; Rotbart HA; Feldman S; Dunkle LM; Feder HM; Prober CG; Hayden GF; Steinberg S; Whitley RJ; Goldberg L
    J Pediatr; 1992 Apr; 120(4 Pt 1):627-33. PubMed ID: 1313098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in the Number of Varicella-Zoster Virus-Specific T-Cells in Immunocompromised Children with Varicella.
    Murata K; Hoshina T; Onoyama S; Tanaka T; Kanno S; Ishimura M; Koga Y; Nakayama H; Ohga S
    Tohoku J Exp Med; 2020 Mar; 250(3):181-190. PubMed ID: 32213753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in chickenpox (varicella-zoster) infection?
    Gershon AA
    West J Med; 1993 Feb; 158(2):180. PubMed ID: 8382001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir treatment of varicella in otherwise healthy children.
    Balfour HH; Kelly JM; Suarez CS; Heussner RC; Englund JA; Crane DD; McGuirt PV; Clemmer AF; Aeppli DM
    J Pediatr; 1990 Apr; 116(4):633-9. PubMed ID: 2156984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.
    Baiker A; Haase R; Eberle J; Vizoso Pinto MG; Pfrepper KI; Petrich A; Deml L; Campe H; Nitschko H; Jaeger G
    Virol J; 2010 Mar; 7():54. PubMed ID: 20205920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir prevents dissemination of varicella in immunocompromised children.
    Nyerges G; Meszner Z; Gyarmati E; Kerpel-Fronius S
    J Infect Dis; 1988 Feb; 157(2):309-13. PubMed ID: 2826611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.
    Gershon AA; Steinberg SP
    Infect Immun; 1979 Jul; 25(1):170-4. PubMed ID: 225270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of acyclovir for chickenpox in normal children.
    Dunkle LM; Arvin AM; Whitley RJ; Rotbart HA; Feder HM; Feldman S; Gershon AA; Levy ML; Hayden GF; McGuirt PV
    N Engl J Med; 1991 Nov; 325(22):1539-44. PubMed ID: 1944438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.
    Ogunjimi B; Smits E; Hens N; Hens A; Lenders K; Ieven M; Van Tendeloo V; Van Damme P; Beutels P
    Viral Immunol; 2011 Apr; 24(2):151-7. PubMed ID: 21449725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.